1. Parisi R, Webb RT, Kleyn CE, Carr MJ, Kapur N, Griffiths CEM, et al. Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study. Br J Dermatol. 2019;180(1):108–15. [
DOI]
2. Ali FM, Cueva AC, Vyas J, Atwan AA, Salek MS, Finlay AY, et al. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis. Br J Dermatol. 2017;176(3):577–93. [
DOI]
3. Gündüz A, Topçuoğlu V, Usta Gündüz EB, Ergun T, Gencosmanoglu DS, Sungur MZ. Significant effects of body image on sexual functions and satisfaction in psoriasis patients. J Sex Marital Ther. 2020;46(2):160–9. [
DOI]
4. Founta O, Adamzik K, Tobin AM, Kirby B, Hevey D. Psychological distress, alexithymia and alcohol misuse in patients with psoriasis: a cross-sectional study. J Clin Psychol Med Settings. 2019;26(2):200–19. [
DOI]
5. Deveci E, Kocacenk T, Şahan E, Yılmaz O, Öztürk A, Kırpınar İ. Oxidative stress and inflammatory response in patients with psoriasis; is there any relationship with psychiatric comorbidity and cognitive functions? Psychiatry and Clinical Psychopharmacology. 2019;29(4):682–95. [
DOI]
6. Korman AM, Hill D, Alikhan A, Feldman SR. Impact and management of depression in psoriasis patients. Expert Opin Pharmacother. 2016;17(2):147–52. [
DOI]
7. Egeberg A, Thyssen JP, Wu JJ, Skov L. Risk of first‐time and recurrent depression in patients with psoriasis: a population‐based cohort study. Br J Dermatol. 2019;180(1):116–21. [
DOI]
8. Erdogan H, Altinoz A, Acer E, Saracoglu Z, Bilgin M. Evaluation of anxiety sensitivity in patients with psoriasis. Dermatol Sin. 2019;37(1):28. [
DOI]
9. Chen A, Beck KM, Tan E, Koo J. Stigmatization in psoriasis. J Psoriasis Psoriatic Arthritis. 2018;3(3):100–6. [
DOI]
10. Ghorbanibirgani A, Fallahi-Khoshknab M, Zarea K, Abedi H. The lived experience of psoriasis patients from social stigma and rejection: a qualitative study. Iran Red Crescent Med J. 2016;18(7):e27893. [
DOI]
11. Obradors M, Blanch C, Comellas M, Figueras M, Lizan L. Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Qual Life Res. 2016;25(11):2739–54. [
DOI]
12. Rosińska M, Rzepa T, Szramka-Pawlak B, Żaba R. Body image and depressive symptoms in person suffering from psoriasis. Psychiatr Pol. 2017;51(6):1145–52. [
DOI]
13. Annunziata MA, Giovannini L, Muzzatti B. Assessing the body image: relevance, application and instruments for oncological settings. Support Care Cancer. 2012;20(5):901–7. [
DOI]
14. Wynne C, Comiskey C, McGilloway S. The role of body mass index, weight change desires and depressive symptoms in the health-related quality of life of children living in urban disadvantage: testing mediation models. Psychology & Health. 2016;31(2):147–65. [
DOI]
15. Teo I, Reece GP, Christie IC, Guindani M, Markey MK, Heinberg LJ, et al. Body image and quality of life of breast cancer patients: influence of timing and stage of breast reconstruction: Body image and breast reconstruction. Psycho-Oncology. 2016;25(9):1106–12. [
DOI]
16. American Psychiatric Association. DSM-5. Seyed Mohammadi Y. (Persian translator). Tehran: Ravan Publication; 2019.
17. Słomian A, Łakuta P, Bergler-Czop B, Brzezińska-Wcisło L. Self-esteem is related to anxiety in psoriasis patients: a case control study. J Psychosom Res. 2018;114:45–9. [
DOI]
18. Ferreira BI, Abreu JL, Dos Reis JP, Figueiredo AM. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9(6):36–43.
19. Cvitanovic H, Jancic E. Influence of stressful life events on coping in psoriasis. Coll Antropol. 2014;38(4):1237–40.
20. Lamb RC, Matcham F, Turner MA, Rayner L, Simpson A, Hotopf M, et al. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. Br J Dermatol. 2017;176(4):1028–34. [
DOI]
21. Pujol RM, Puig L, Daudén E, Sánchez-Carazo JL, Toribio J, Vanaclocha F, et al. Mental health self-assessment in patients with moderate to severe psoriasis: an observational, multicenter study of 1164 patients in Spain (the VACAP study). Actas Dermosifiliográficas. 2013;104(10):897–903. [
DOI]
22. Innamorati M, Quinto RM, Lester D, Iani L, Graceffa D, Bonifati C. Cognitive impairment in patients with psoriasis: a matched case-control study. J Psychosom Res. 2018;105:99–105. [
DOI]
23. World Health Organization. Depression and other common mental disorders: global health estimates. World Health Organization; 2017.
24. Wojtyna E, Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. Gender, body image and social support: biopsychosocial determinants of depression among patients with psoriasis. Acta Derm Venerol. 2017;97(1):91–7. [
DOI]
25. Pompili M, Innamorati M, Erbuto D, Costanzo A. Psychiatric comorbidity and suicide risk in patients with psoriasis. European Psychiatry. 2016;33(1):395–6. [
DOI]
26. Gruchała A, Marski K, Zalewska-Janowska A. Psychotherapeutic methods in psoriasis. Our Dermatol Online. 2020;11(2):113–9. [
DOI]
27. Bayegan K, Sotodeh Asl N, Karami A, Asadzadeh Daraei H. Comparison of the effectiveness of metacognitive therapy and behavioral activation on depression in elderly with type 2 diabetes. Avicenna J Neuro Psycho Physiology. 2020;7(1):9–14. [
DOI]
28. Pour Mohammad Ghouchani K, Madhi S, Forootan Nejad K. The effectiveness of behavioral activation therapy on metacognitive beliefs and concerns of physical image of depressed girl students. Rooyesh. 2020;8(10):133–42. [Persian] [
Article]
29. Fernández-Rodríguez C, González-Fernández S, Coto-Lesmes R, Pedrosa I. Behavioral activation and acceptance and commitment therapy in the treatment of anxiety and depression in cancer survivors: a randomized clinical trial. Behav Modif. 2021;45(5):822–59. [
DOI]
30. Gholamrezaei S, Yousefvand M, Ghazanfari F, Farokhzadian AA. The effectiveness of meta cognitive therapy in meta cognitive beliefs change and body image concern (BICI) of depressed female high school students. Instruction and Evaluation. 2018;10(40):105–27. [Persian] [
Article]
31. Callesen P, Reeves D, Heal C, Wells A. Metacognitive therapy versus cognitive behaviour therapy in adults with major depression: a parallel single-blind randomised Trial. Sci Rep. 2020;10(1):7878. [
DOI]
32. Thorslund J, McEvoy PM, Anderson RA. Group metacognitive therapy for adolescents with anxiety and depressive disorders: a pilot study. J Clin Psychol. 2020;76(4):625–45. [
DOI]
33. Chu BC, Crocco ST, Esseling P, Areizaga MJ, Lindner AM, Skriner LC. Transdiagnostic group behavioral activation and exposure therapy for youth anxiety and depression: initial randomized controlled trial. Behav Res Ther. 2016;76:65–75. [
DOI]
34. Nagy GA, Cernasov P, Pisoni A, Walsh E, Dichter GS, Smoski MJ. Reward network modulation as a mechanism of change in behavioral activation. Behav Modif. 2020;44(2):186–213. [
DOI]
35. Wells A. Metacognitive therapy for anxiety and depression. Mohammadkhani SH. (Persian translator). Tehran: Ebn-e-Sina Publication; 2016.
36. Dammen T, Papageorgiou C, Wells A. An open trial of group metacognitive therapy for depression in Norway. Nord J Psychiatry. 2015;69(2):126–31. [
DOI]
37. Hoffart A, Johnson SU, Nordahl HM, Wells A. Mechanisms of change in metacognitive and cognitive behavioral therapy for treatment-resistant anxiety: the role of metacognitive beliefs and coping strategies. J Exp Psychopathol. 2018;9(3):204380871878741. [
DOI]
38. Delavar A. Educational and psychological research. Tehran: Virayesh Pub; 2015. [Persian]
39. Littleton HL, Axsom D, Pury CLS. Development of The Body Image Concern Inventory. Behav Res Ther. 2005;43(2):229–41. [
DOI]
40. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–5. [
DOI]
41. Beck A, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
42. Pooravari M, Habibi M, Abedi Parija H, Seyed Ali Tabar SH. Psychometric properties of body image concern inventory in adolescent. Pejouhandeh. 2014;19(4):189–99. [Persian] [
Article]
43. Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14(1):61–8. [
DOI]
44. Slater P, Bunting B, Hasson F, Al-Smadi AM, Gammouh OS, Ashour A, et al. An examination of factor structure of the hamilton anxiety rating scale in a non-clinical Persian sample. Int J Res Nurs. 2019;10(1):1–9. [
DOI]
45. Taheri Tanjani P, Garmaroudi G, Azadbakht M, Fekrizadeh Z, Hamidi R, Fathizadeh S, et al. Validity and reliability Beck Depression Inventory-II among the Iranian elderly population. Journal of Sabzevar University of Medical Sciences. 2015;22(1):189–98. [Persian] [
Article]
46. Kanter JW, Diéguez Hurtado G, Rusch LC, Busch AM, Santiago-Rivera A. Behavioral activation for Latinos with depression. Clinical Case Studies. 2008;7(6):491–506. [
DOI]
47. Ferguson GA, Takane Y. Statistical analysis in psychology and education. Delavar A, Naghshbandi S. (Persian translator). Tehran: Arasbaran Publication; 2007.
48. Wells A, Fisher P, Myers S, Wheatley J, Patel T, Brewin CR. Metacognitive therapy in recurrent and persistent depression: a multiple-baseline study of a new treatment. Cogn Ther Res. 2009;33(3):291–300. [
DOI]